Pfizer Asks Supreme Court To Protect “Right Of Reply” In Cases Like ALLHAT

The ALLHAT study report illustrates why manufacturers need a clearly articulated "right of reply" under the First Amendment, Pfizer told the Supreme Court in an amicus curiae brief filed in support of Nike's appeal of Kasky v. Nike